Skip to content

EXACARE FARMA

Active
Private limited companyfounded 2017active for 9 yearsEksaarde-dorp 4A, 9160 Lokeren, BelgiumKBO/BCE: BE 0678.503.419

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

EXACARE FARMA has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €179,242 and a net result of €231,753. Equity has been stable since 2018 (±1.9% per year). Its solvency ranks better than 23% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Official details

KBO
Status
Active since 12-07-2017 Normal situation
Legal form
Private limited company
Registered office
Eksaarde-dorp 4A, 9160 Lokeren
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.269.365.082 9160 Lokeren, since 12-07-2017
Financial year end
31 December
Peppol
Reachable since 08-01-2026

Board and ownership

Board

Financial position

81 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts 2025
Gross margin
€514,488
▲ 2.0%
Turnover
≈ €1.9m
estimated
Profit
€231,753
▲ 3.8%
Equity
€179,242
▲ 1.0%
Total assets
€1.4m
▼ 12.1%
Staff
1.8 FTE
=
2025 accounts filed 6 days after the deadline
Filed on 06-08-2026at the National Bank
Score breakdownraises riskEquity €179,242 (12.8% of total assets)Sector: Retail trade (NACE 47)lowers riskFigures for financial year 2025 (filed on 13-08-2026)Size: 1.8 FTE, total assets €1.4mShow the evidence

Checked score

Score 2025
81 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 51% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 38+2
equity 12.8% of total assets
Liquidity 48-5
short-term debt 38.2% · cash 12.3%
Profitability 89+3
return on assets 16.5%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.9%▲ +0.2 percentage points vs 05-2025 07-2025: 1.0%▲ +0.1 percentage points vs 06-2025 08-2025: 1.6%▲ +0.6 percentage points vs 07-2025highest value 09-2025: 0.6%▼ -1.0 percentage point vs 08-2025 10-2025: 0.6%● unchanged vs 09-2025 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.7%▲ +0.1 percentage points vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.8%▲ +0.1 percentage points vs 05-2026 07-2026: 0.9%▲ +0.1 percentage points vs 06-2026 08-2026: 1.4%▲ +0.5 percentage points vs 07-2026 09-2026: 0.6%▼ -0.8 percentage points vs 08-2026 10-2026: 0.6%● unchanged vs 09-2026lowest value
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.07 (1.1 in 2024), below the usual 1.5. Short-term debt is 38.2% and cash 12.3% of total assets. 87.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 29% of them on solvency, 47% on liquidity, 84% on profitability and 43% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Equity €179,242 (12.8% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-08-2026)
NBB · annual accounts
lowers risk · Size: 1.8 FTE, total assets €1.4m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 12757 sector peers (2025).
NBB · sector comparison
Position among 12757 sector peers
Solvency
better than 23%
← weakest strongest →
raises risk · 2025 accounts filed 6 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-08-2026, 6 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 8 filings
Deviation from the deadline
2025
6 days late
2024
1 day late
2023
13 days late
2022
4 days early
2021
23 days late
2020
24 days late
2019
11 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 90% of companies in retail tradesector median €27,641 · 12,747 companies €231,753 View
  • Positive: 8 profitable years in a rowprofit 2025: €231,753 8 years View

Documents

Annual accounts at the NBB

All 8 annual accounts

Articles and registers

Key facts about EXACARE FARMA

What is the company number of EXACARE FARMA?
The company number of EXACARE FARMA is 0678.503.419. The VAT number is the same number with BE in front: BE 0678.503.419.
Where is EXACARE FARMA based?
The registered office is at Eksaarde-dorp 4A, 9160 Lokeren.Company details
What does EXACARE FARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of EXACARE FARMA?
The legal form of EXACARE FARMA is Private limited company (BV).
When was EXACARE FARMA founded?
EXACARE FARMA was founded on 12-07-2017.
Is EXACARE FARMA still active?
Yes, EXACARE FARMA is an active enterprise in the KBO register.
How many employees does EXACARE FARMA have?
EXACARE FARMA had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of EXACARE FARMA?
The turnover in financial year 2025 is ≈ €1.9m. This figure is estimated from the gross margin of €514,488 and 47 comparable companies (NACE 477). It probably lies between €1.5m and €3.1m.
Is EXACARE FARMA profitable?
In financial year 2025, EXACARE FARMA made a profit of €231,753.
Where can I find the annual accounts of EXACARE FARMA?
EXACARE FARMA filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of EXACARE FARMA due?
EXACARE FARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as EXACARE FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.9m, founded between 2012 and 2019.

CompanyTotal assetsGross margin
EXACARE FARMA Lokeren€1.4m€0.5m
APOTHEEK POLLET LORENZ Deinze€1.4m€0.4m
Apotheek Lynn Vander Stricht Berlare€1.6m€0.4m
APOTHEEK SOETE Brugge€1.1m€0.4m
VIRCO PHARMA Hoeilaart€1.9m€0.5m
Pharmacie Loop Braine-le-Château€1.8m€0.5m
Apotheek Oude Brug Lokeren€1.0m€0.3m
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.